Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | 3-oxoacyl-[acyl-carrier-protein] synthase III | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Conserved hypothetical protein | 3-oxoacyl-[acyl-carrier-protein] synthase III | 317 aa | 265 aa | 26.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | fatty acid elongase, putative | 0.005 | 0.0871 | 0.5 |
Echinococcus granulosus | microsomal glutathione S transferase 3 | 0.0117 | 0.2206 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0383 | 0.7449 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.005 | 0.0871 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.005 | 0.0871 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0383 | 0.7449 | 0.5 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.0383 | 0.7449 | 0.5 |
Schistosoma mansoni | microsomal glutathione s-transferase | 0.0117 | 0.2206 | 0.2206 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0383 | 0.7449 | 0.5 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0019 | 0.0271 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0019 | 0.0271 | 0.1229 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0383 | 0.7449 | 0.5 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0019 | 0.0271 | 1 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0018 | 0.0246 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.005 | 0.0871 | 0.5 |
Echinococcus multilocularis | microsomal glutathione S transferase 3 | 0.0117 | 0.2206 | 1 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0019 | 0.0271 | 0.1229 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0383 | 0.7449 | 0.5 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0383 | 0.7449 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0021 | 0.0306 | 0.0306 |
Toxoplasma gondii | MAPEG family protein | 0.0117 | 0.2206 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0383 | 0.7449 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0221 | 0.8141 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0021 | 0.0306 | 0.0306 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0018 | 0.0246 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.005 | 0.0871 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.